Latest Reimbursement News

Global Health Limited reported a robust 22% increase in customer receipts for the December 2024 quarter, alongside a significant improvement in operating cash flow, positioning the company well amid ongoing healthcare sector challenges.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

OD6 Metals has completed the acquisition of the historic Gulf Creek Copper Project in New South Wales, positioning itself to unlock significant copper potential using modern exploration techniques.

HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.